Evolocumab in patients with homozygous familial hypercholesterolemia in India
Sandeep Bansal, Andrea Ruzza, JPS Sawhney, Govind Kulkarni, Shammana Iyengar, Vimal Mehta, Andrew Hamer, You Wu, Frederick J. Raal
Topics & Concepts
EvolocumabMedicineTolerabilityDiscontinuationPCSK9Familial hypercholesterolemiaAlirocumabAdverse effectInternal medicineClinical endpointGastroenterologyApolipoprotein BLipoproteinCholesterolClinical trialApolipoprotein A1LDL receptorLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders